sc9

SC-9 is a protein kinase C activator.

PNSC928 is an inhibitor of the CtBP2-p300 interaction, with an IC50 of 23.60 µM. It can reverse the expression of pro-inflammatory cytokines induced by Lipopolysaccharides in RAW264.7 cells. Additionally, PNSC928 has the potential to ameliorate acute respiratory distress syndrome (ARDS) in mice.

NSC90616 is a compound that rescues mutant p53 [1].

SC99 is a selective inhibitor of JAK2-STAT3 activation. SC99 downregulates the expression of STAT3-modulated genes.SC99 inhibits platelet activation, aggregation and displays potent anti-myeloma, anti-thrombotic activities

SC912 is an AR-V7 inhibitor with an IC50 of 0.36 μM. It directly binds to AR-FL and AR-V7 proteins, preventing their nuclear localization and chromatin binding. SC912 can exert anticancer effects by suppressing cell proliferation, inducing cell cycle arrest, and promoting apoptosis.